Shares of major hospital chains rose sharply on Monday, November 16, with Max Healthcare, Apollo Hospitals, Fortis Healthcare and Aster DM gaining between 2% and 6%.
The gains come after a recent sell-off in hospital stocks, triggered by concerns over potential regulatory intervention in healthcare pricing. However, some market participants see the correction as a buying opportunity, arguing that India’s structural shortage of hospital beds and rising demand continue to support the sector’s long-term growth prospects.
Among the stocks, Max Healthcare was the top gainer, trading 5.90% up at ₹1,000.75 around 1.15 pm. Fortis Healthcare advanced 4.54% to ₹798.65, while Aster DM Healthcare gained 4.42% to ₹754.40. Apollo Hospitals was up 2.40% at ₹8,730.50.
The recent weakness in the sector followed concerns around possible regulatory intervention in healthcare pricing. In September, the Supreme Court also questioned the Centre on the possibility of applying a uniform 16% markup across medicines, while raising concerns over pricing practices at corporate hospitals, including the requirement for patients to buy medicines from in-house pharmacies or specified chemists.
The regulatory scrutiny has added to concerns about the potential impact on hospital profitability. However, last month, Aditya Khemka, Fund Manager at InCred, said he believes the correction could offer an attractive entry point for investors.
Khemka said previous episodes of price regulation in 2017 and 2019, involving stents, knee implants and certain medicines, had eventually presented buying opportunities.
“Hospital prices corrected proved to be a phenomenal entry point. Seems like it’s a repeat of the cycle,” he said.
According to Khemka, hospitals operate as platform businesses, bringing patients and doctors together while providing the required infrastructure.
He said hospitals could adjust prices across other parts of their service offerings if regulators impose margin caps on specific segments. Most listed hospital chains generate a return on equity (ROE) of around 15-20%, against an assumed cost of capital of about 15%, he noted.
A key structural factor supporting the sector is India’s shortage of hospital beds. The country has around 15 beds per 10,000 people, including government facilities, compared with a global average of 35. Developed markets such as Japan and South Korea have around 120 beds per 10,000 people.
Hospital stocks: Max Healthcare, Fortis, Aster DM lead gains after recent sell-off

Hindustan Zinc plans ₹80,000 crore expansion, targets 2 MTPA metal capacity in 3-5 years
Nov 16, 2026

Suzlon Energy, Premier, Waaree shares fall up to 7% after peers report disappointing Q2 results
Nov 16, 2026

DIPAM Secretary Arunish Chawla explains how Coal India will get its funding needs for the future: Exclusive
Nov 16, 2026

Banks, autos, industrials top picks as market recovery gathers pace: Lighthouse’s Laijawala
Nov 16, 2026
